Biochem/physiol Actions
Reversible: yes
Target Ki: 11 µM against protein kinase A
Product does not compete with ATP.
Cell permeable: yes
Primary TargetPKA
General description
A cell-permeable and reversible inhibitor of protein kinase A (Ki = 11 µM). Resistant to hydrolysis by phosphodiesterases. Noncompetitive with respect to ATP.
Cell permeable inhibitor of protein kinase A (Ki = 11 µM). Resistant to hydrolysis by phosphodiesterases. Note: 5 µmol = 2.23 mg
Note: 5 µmol = 2.23 mg.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Other Notes
Kaji, H., et al. 1992. Biochem. Biophys. Res. Commun. 182, 1356.Van der Kloot, W., and Branisteanu, D.D. 1992. Eur. J. Phys.420, 336.Yokozaki, H., et al. 1992. Cancer Res.52, 2504. Butt, E., et al. 1990. FEBS Lett.263, 47.Dostmann, W.R., et al. 1990. J. Biol. Chem.265, 10484.Rothermel, J.D. 1988. Biochem. J. 251, 757.Eckstein, F. 1985. Annu. Rev. Biochem.54, 367.de Wit, R.J., et al. 1984. Eur. J. Biochem.142, 255.O′Brian, C.A., et al. 1982. Biochemistry21, 4371.
Packaging
5 µmol in Glass bottle
Reconstitution
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
Warning
Toxicity: Standard Handling (A)
This product has met the following criteria to qualify for the following awards: